Veery Capital, LLC Astrazeneca PLC Transaction History
Veery Capital, LLC
- $262 Million
- Q4 2024
A detailed history of Veery Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Veery Capital, LLC holds 3,503 shares of AZN stock, worth $252,180. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,503
Previous 3,346
4.69%
Holding current value
$252,180
Previous $260,000
11.92%
% of portfolio
0.09%
Previous 0.1%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,350Shares Held
477MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.53 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$3.02 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.68 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.65 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.38 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...